Podcasts about manero

73 incendios se mantienen activos en 20 estados: Conafor 27 personas han muerto tras el desplome de un techo en República DominicanaMás información en nuestro podcast

No fue extradición aclara Gertz ManeroNo hay afectaciones tras sismo en Guerrero: SheinbaumMás información en nuestro podcast

El fiscal general de la república, Alejandro Gertz Manero, reveló que desde julio del año pasado México solicitó a Estados Unidos la extradición del narcotraficante Ismael ‘El Mayo’ Zambada; gertz Manero detalló que desde el mes de diciembre las autoridades estadounidenses confirmaron la recepción de la solicitud, sin embargo, hasta el momento no se ha dado respuesta. Así lo informó hoy en la conferencia matutina. Luego de que ayer, Donald Trump aseguró que la aplicación de aranceles a productos mexicanos y canadienses, a partir del 4 de marzo, va hacia adelante, la presidenta Claudia Sheinbaum reiteró que espera se llegue a un acuerdo para frenarlos y señaló que se debe de escuchar completa la declaración de su homólogo estadounidense, incluyendo la parte de la reciprocidad, así lo explicó esta mañana en palacio nacional Además, el secretario de seguridad y protección ciudadana, Omar García Harfuch, aclaró que en el operativo realizado en Sinaloa en días pasados, se tenía como objetivo capturar a Kevin Alonso “N”, alías “el 200”, y a Gustavo “N”, alías “el güerito”, presuntos operadores cercanos de Iván Archivaldo Guzmán, líder de “los chapitos”, descartando la información de que Iván Archivaldo hubiera escapado de las autoridades mexicanas por un túnel. A través de un operativo autoridades federales y estatales capturaron a Jesús R, alias “Don Chuy”, identificado como jefe de plaza del cártel Jalisco nueva generación en el municipio Zacapu, Michoacán. Este evento ocasionó enfrentamientos a balazos entre autoridades y civiles armados, además de reportarse 4 vehículos incendiados en carreteras del estado. Anoche, Campeche se convirtió en el estado número 22 en aprobar la despenalización del aborto; la sesión del congreso se realizó a puerta cerrada. La iniciativa fue presentada por la comisión estatal de derechos humanos y respaldada por la sociedad civil y diversas agrupaciones. Anteriormente, el código penal estatal consideraba como causas de exclusión cuando el embarazo era resultado de una violación, representaba un riesgo de la salud o si se trataba de un aborto involuntario. El INEGI informó que de enero a septiembre de 2024 se registraron 610 mil 404 defunciones en México, que representa un incremento de 14 mil 254 muertes respecto a las registradas en el mismo periodo de 2023. El instituto detalló que las tres principales causas de defunción a nivel nacional fueron las enfermedades del corazón, la diabetes mellitus y los tumores malignos, tanto para mujeres como para hombres. Con información de reporteros y corresponsales para MVS Noticias, Jiro Montes de Oca.See omnystudio.com/listener for privacy information.

It's a special episode this week as we are joined by Hugo Manero, president of Dolfan Club España, to chat about the Dolphins hosting the first-ever regular-season game in Madrid as part of the 2025 International Games! We discuss fan reaction to the news, the NFL in Spain, Bernabéu Stadium, and more about Madrid!See omnystudio.com/listener for privacy information.

Sheinbaum no ha sido invitada a la toma de protesta de Donald Trump como Presidente de EU ¡No al cambio de nombre de la colonia Finesa por 4T! Vecinos se reúnen con autoridadesFéretro del expresidente Jimmy Carter es trasladado al Capitolio de EUMás información en nuestro podcast

Conversamos con Sergio Manero, Strategic Partner Manager de Evertec , sobre el crecimiento de Evertec en Chile y la región, innovación en pagos digitales y cómo están impulsando la transformación tecnológica en sectores como banca, retail y servicios.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/XNT865. CME/MOC/AAPA credit will be available until January 5, 2026.Shifting to Higher Standards in MDS: Custom and Innovative Care to Improve Outcomes for Lower- and Higher-Risk Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Myelodysplastic Syndromes. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AbbVie, Bristol Myers Squibb, and Geron.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/XNT865. CME/MOC/AAPA credit will be available until January 5, 2026.Shifting to Higher Standards in MDS: Custom and Innovative Care to Improve Outcomes for Lower- and Higher-Risk Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Myelodysplastic Syndromes. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AbbVie, Bristol Myers Squibb, and Geron.Disclosure information is available at the beginning of the video presentation.

En esta edición de No Hay Derecho abordaremos, entre otros temas: - Pobreza multidimensional: Gobierno de Dina Boluarte vulnera autonomía del INEI y cambia la fórmula de medición de indicadores. - Dina Boluarte por Año Nuevo: "2025 podrá ser mejor si dejamos de dispararnos a los pies". - El ministro Ángel Manero se mofa de agricultor ciudadano que pedía apoyo: "No esperen todo del Estado". - Escolta de de la presidenta es enviada a España por dos años: ‘La sombra’ es testigo clave en caso ‘El Cofre’. - Rafael Vela y Jorge Chávez Cotrina: estos son los nuevos cambios dentro del Ministerio Público. - Caso Lava Jato: PJ resuelve este 6 de enero si excluye a Renovación Popular de investigación por lavado de activos. - Denuncian que César Acuña estaría detrás de la censura del presidente de la Comisión de Fiscalización que investiga el caso de prostitución en el Congreso.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/XNT865. CME/MOC/AAPA credit will be available until January 5, 2026.Shifting to Higher Standards in MDS: Custom and Innovative Care to Improve Outcomes for Lower- and Higher-Risk Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Myelodysplastic Syndromes. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AbbVie, Bristol Myers Squibb, and Geron.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/XNT865. CME/MOC/AAPA credit will be available until January 5, 2026.Shifting to Higher Standards in MDS: Custom and Innovative Care to Improve Outcomes for Lower- and Higher-Risk Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Myelodysplastic Syndromes. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AbbVie, Bristol Myers Squibb, and Geron.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/XNT865. CME/MOC/AAPA credit will be available until January 5, 2026.Shifting to Higher Standards in MDS: Custom and Innovative Care to Improve Outcomes for Lower- and Higher-Risk Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Myelodysplastic Syndromes. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AbbVie, Bristol Myers Squibb, and Geron.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/XNT865. CME/MOC/AAPA credit will be available until January 5, 2026.Shifting to Higher Standards in MDS: Custom and Innovative Care to Improve Outcomes for Lower- and Higher-Risk Disease In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Myelodysplastic Syndromes. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AbbVie, Bristol Myers Squibb, and Geron.Disclosure information is available at the beginning of the video presentation.

Osiel Cárdenas tendrá que responder por delincuencia organizada ante tribunales Sobre educación hablamos con el presidente de colombia: Sheinbaum  Arruinada la economía de Palestina por la guerra: Banco Mundial Más información en nuestro podcast

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/SZU865. CME/MOC/NCPD/CPE credit will be available until October 5, 2025.Resetting Standards in MDS: New Principles for Integrating Innovative Therapy Into Risk-Adapted Care In support of improving patient care, Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis educational activity is supported through medical education grants from Bristol Myers Squibb and Geron.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/SZU865. CME/MOC/NCPD/CPE credit will be available until October 5, 2025.Resetting Standards in MDS: New Principles for Integrating Innovative Therapy Into Risk-Adapted Care In support of improving patient care, Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis educational activity is supported through medical education grants from Bristol Myers Squibb and Geron.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/SZU865. CME/MOC/NCPD/CPE credit will be available until October 5, 2025.Resetting Standards in MDS: New Principles for Integrating Innovative Therapy Into Risk-Adapted Care In support of improving patient care, Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis educational activity is supported through medical education grants from Bristol Myers Squibb and Geron.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/SZU865. CME/MOC/NCPD/CPE credit will be available until October 5, 2025.Resetting Standards in MDS: New Principles for Integrating Innovative Therapy Into Risk-Adapted Care In support of improving patient care, Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis educational activity is supported through medical education grants from Bristol Myers Squibb and Geron.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/SZU865. CME/MOC/NCPD/CPE credit will be available until October 5, 2025.Resetting Standards in MDS: New Principles for Integrating Innovative Therapy Into Risk-Adapted Care In support of improving patient care, Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis educational activity is supported through medical education grants from Bristol Myers Squibb and Geron.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/SZU865. CME/MOC/NCPD/CPE credit will be available until October 5, 2025.Resetting Standards in MDS: New Principles for Integrating Innovative Therapy Into Risk-Adapted Care In support of improving patient care, Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis educational activity is supported through medical education grants from Bristol Myers Squibb and Geron.Disclosure information is available at the beginning of the video presentation.

Bonjour à tous et bienvenue dans ce 11ème épisode de "Potentiel 2 Manager". Dans ce 11ᵉ épisode, j'ai le plaisir d'interviewer Yannis Manero, ancien gardien de but professionnel devenu entrepreneur.Points forts de l'épisode :Préparation physique et mentale : Inspirez-vous des méthodes d'entraînement des athlètes pour développer vos équipes.Valeurs du sport collectif : Découvrez comment la rigueur et l'esprit d'équipe peuvent renforcer la cohésion en entreprise.Gestion et motivation : Apprenez des stratégies pratiques de coaching sportif appliquées au management.Bien-être mental : Abordez l'importance du bien-être mental des employés dans la culture d'entreprise.Un échange enrichissant sur les valeurs du sport dans le développement personnel et professionnel !

Alejandro Gertz Manero permanece frente a la FGR  No tenemos reunión programada con el gobernador de Sinaloa afirma SheinbaumMigrantes denuncian abusos físicos y verbales de la Patrulla Fronteriza de EUMás información en nuestro podcast

Dr Garcia-Manero discusses findings from research in myelodysplastic syndromes that were presented at the 2024 EHA Congress.

¿Qué tan severa es la situación de hambre en Lima? El ministro Ángel Manero, titular de la cartera de Desarrollo Agrario, fue duramente criticado tras sus declaraciones en las que afirmaba que en el Perú se come de manera contundente, y tras sus críticas al informe de inseguridad alimentaria de la FAO. Analizamos la situación alimentaria a nivel nacional.See omnystudio.com/listener for privacy information.

¿Qué tan severa es la situación de hambre en Lima? El ministro Ángel Manero, titular de la cartera de Desarrollo Agrario, fue duramente criticado tras sus declaraciones en las que afirmaba que en el Perú se come de manera contundente, y tras sus críticas al informe de inseguridad alimentaria de la FAO. Analizamos la situación alimentaria a nivel nacional.See omnystudio.com/listener for privacy information.

Escucha aquí la opinión de Glatzer Tuesta, conductor del programa No Hay Derecho. En esta edición de No Hay Derecho abordaremos, entre otros temas: - Quinto Inuma: Poder Judicial dicta prisión preventiva para principal sospechoso del crimen contra el líder indígena kichwa. - Organismos nacionales e internacionales se pronuncian en contra de la denominada Ley de Impunidad. - Ministro de Desarrollo Agrario Ángel Manero sostiene su posición sobre que en el Perú no hay crisis alimentaria como afirma la FAO. - Ministro del Interior sobre Vladimir Cerrón: “Estamos cerca, sabemos su ubicación”. - Defensor del Pueblo Josué Gutiérrez reconoce que no consultó con personal externo demanda contra ley de extinción de dominio. - Dina Boluarte sigue muy desaprobada y amplia mayoría no le cree nada.

Jeremy's Best Decision.by senorlongo. Listen to the ► Podcast at Connected.Chapter 15.MP put the locket back over her head, swearing once again to never remove it. She took my hand and led me upstairs. Had anyone ever questioned my mother's magical powers, they would have been silenced by seeing my room. We had a big house; a colonial with five bedrooms and five and a half baths. I had the biggest after the master suite; 12 by 12 with a small walk-in closet and private bath. Now the room was 12 by 20. Mom had removed the wall, merged the two carpets and changed the color, fixed the walls and ceiling, and painted the room. Gone were my boyish decorations, replaced by accents more suitable for a young couple, which, of course, we were. The walls were a light creamy color, the carpet a light mauve. In the middle of the long wall was a queen sized bed flanked by a dresser for MP and an armoire for me. On the opposite wall between windows that had been moved apart since I was last there were identical desks, each with its own computer and monitor networked to a color laser printer and a large flat screen TV. Most important was the second closet because I knew MP had a ton of clothes. Also, my bathroom had a stall shower; the other had a tub which I was sure we'd use together sometime in the future.The next day, after her father had gone to work; MP and I walked to her house to pick up whatever clothing we could carry. Her mother came to the door, tears in her eyes.“I'm sorry, Mary Patricia, your father took all your clothes to Goodwill the day you left. There's nothing here. I'm so sorry. I don't know what I'm going to do without you here.” MP hugged her mother, telling her not to worry. We'd keep in touch with her and, after all, we were only two doors away. When she was done, I also hugged and kissed her. “That's for raising the finest person I've ever known; the most loving, caring, most unselfish person in the world. I promise I will love her forever.”When we arrived home, MP told my mother, “It's not a big deal. I can get underwear and almost everything else I need at Wal-Mart.”Scowling, Mom replied, “No daughter of mine is going to buy her underwear or anything else at Wal-Mart! Wait here, Jeremy.” She left, walking up the stairs in a hurry. She returned a moment later handing me more than $3,000. “You don't have a credit card so take the cash. Take MP to Victoria's Secret first, then to some of the other boutiques in town. If you run out of money I'll get you more. MP, buy what you want, don't skimp on account of the cost.” She shooed us out the door.I absolutely hate shopping and sitting in Victoria's Secret among all the bras and panties was embarrassing, but MP made it all worthwhile when she told me she'd give me a special show when we got home. All told we spent five agonizing hours buying her new clothes and shoes. Why girls need so many shoes was a mystery to me. We put all of it into her closet except for one box which she refused to show me. “Later,” she said kissing me gently on the cheek.After dinner we retired to our room. I was still pretty well wiped out from my ordeal of the past few weeks. I may be a wizard, but I'm also human; I need sleep like anyone else. I led MP to the bathroom, planning on showering together, but she shook her head “no.” “Not tonight, I have something special for you and I want it to be a surprise.” She kissed me; just a little peck; and left. I showered and climbed into bed naked, turning the lights out. A few minutes later MP emerged from the other bath. She was wearing the sheerest baby doll lingerie I'd ever seen. It was a burnt-orange color that exactly matched her flaming angelic blonde hair. With the light behind her I could see the silhouette of her perfect body; her slender legs, her curvy hips, the swell of her breasts, and the alluring spread between her legs. It was an incredibly erotic sight. If this was her surprise it was sensational. I forgot immediately how tired I was. I became erect in a millisecond. I started drooling in anticipation of making love with this delightful creature.“You like?” MP whispered, climbing onto the bed next to me.I could barely respond, but somehow I managed to groan, “Oh, yes, I love it; and I love you.”MP pushed me down. “You're going to love this even more,” as she took me into her hot mouth. “Mmm, I love how you taste. You lie back and let me do all the work.” She went back to work on my cock and, if she wasn't careful, I was going to cum in about twenty seconds. MP must have sensed my excitement because she pulled back after licking all around my helmet. She kissed and licked my ball sack then moved up to lay one hell of a kiss on my lips. “I hope you like this because we're going to do it several times every day. I told you I was going to wear you out.”“Yeah? Well, maybe I'll wear you out, so there!” I declared in a weak tone which revealed my own tepid uncertainty.“Ha! That'll never happen. I'll never tire of you. Now that I have you back, I'm never letting you go. I'm going to show you how much I love you every single day.” She kissed me again, her tongue teasing mine, and sucking my lip between her teeth.Again, she gave me a peck on the cheek and lowered herself down my body. Kneeling next to me she licked all around my granite cock before rising up to straddle me. I thought she was lowering her pussy to me but; no! Was I surprised when I felt the tightness of her ass.“That's why we didn't shower together, Jeremy. I wanted to get myself ready for you. We've only done this a couple of times and I still remember how wonderful it was. Now we're going to do it all the time.” Pausing a second, she continued, “We are going to do it all the time, aren't we?”“Oh, yes, MP; we;  certainly;  are,” I grunted, reveling in what her ass was doing to me.The pressure was incredible and when MP began moving up and down the sensations spread throughout my body. I was tingling from head to toe. MP increased her pace, leaning forward and placing my hands on her breasts. I pinched those delicious nipples and rolled them over my fingers. “Do my clit, Jeremy. I just need a little help.” Mary pleaded. I moved my right hand down between our bodies. Her button was hard and hot and her cunt was running like a river. A few gentle rubs threw her over the top. She shook over and over for almost a minute in her ecstasy. I was ready, too. I rammed deep into her bowel as I lifted her more than a foot off the bed. I held her there as I came; jetting into her repeatedly until I was too exhausted to even move.MP fell on top of me. I caressed her head, running my fingers through her silky hair.“If you do that every day you'll probably kill me in a month,” I told her. “Then you'll be a wealthy widow.”“I guess that means we're getting married. Is that a proposal?” She pressed the issue.Holding her head and looking straight into her eyes, I told her, “No, MP; this is a proposal; will you marry me?”“Was there ever a question?” She beamed.“I'll take that as a ‘yes.'” I sealed the contract.“Just so there's no doubt,” she whispered, “Yes; yes; yes!”She rose and I tried to pull her back. She pushed away saying, “I need to clean you up for the morning. You do want me tomorrow morning, don't you?”All I had to do was smile. She was back in a moment with a washcloth and soap. She cleaned me carefully then tested with her tongue. She flashed the Okay sign before climbing in with me. When she draped her leg over mine, I could feel the wetness of her pussy. It was sublimely comforting as we drifted to sleep. I knew we'd be stuck together by morning.Before falling asleep there was something I had to ask her. “MP, are you sure you want to move in? Aren't you going to miss your mom and dad?”“Jeremy, you know how much I love my mother. She's the best, but my dad treats me like I'm eight instead of eighteen. You should have seen the fit he threw when I was over here after Mandy died. I won't miss that one bit.”“Okay,” I replied, “I just wanted to be sure. I wouldn't want to come between you and your family.“Don't worry about that; you are my family now.” She hugged me, laid her head on my chest, and fell asleep. I followed soon after.Chapter 16.I woke in the early morning; my clock said 4:30. MP was tracing circles on my chest. “Jeremy,” she said in the faintest whisper, “are you awake?”“Yes, MP, I guess I'm not used to sleeping like this, but I'm looking forward to getting used to it. What's the matter? Why are you awake?”“I was just thinking; Jeremy; why did you make my boobs grow?”Patiently, I explained, “Mostly because I hated the way those girls were teasing you. You were my best friend other than Ted and Josh. I loved you even then.”“Well, I'm glad you made them grow. If you hadn't, you wouldn't have come over to my house to feel and suck them, and I wouldn't have jerked you off, or given you a blowjob; and then you wouldn't have made me cum, and we wouldn't have fucked or become a couple. So, I guess making them grow was a good decision.”“Huh? MP, how long have you been thinking about this?”“A long time, Jeremy; a very long time.” She stopped tracing circles and moved her hand down to my cock. I was already hard. “Oh, Jeremy,” she cooed, “I think you're ready for me again.”I grabbed her suddenly and rolled her over. She was pinned beneath me, my legs between hers. “You think I'm ready for you? I know I am!” I kissed her hard as I pinched her nipple. She groaned into my mouth. She reached between us to rub my cock into her opening. She was already wet and oozing pussy juice. She pulled me into her as she wrapped her legs around my waist. I pushed hard, forcing myself against her cervix. “Oh, yes, JEREMY, Fuck me! Fuck me harder!” We moved into each other faster and harder. We were working hard for each other; sweat pooled between MP's tits. Our moans and grunts were coming faster and faster. “Oh, Yes! Yes! Yes!” MP was screaming as her orgasm took over her body, shaking and shuddering beneath me. I was pumping her madly until, “Ugh!” My cum poured into MP until, at last, I fell in a heap onto her. I moved her leg, rolled over, kissed her, and held her tight as we, once again, fell asleep.We woke around eight, showered together, and walked into the kitchen in our robes. Mom was there, bags under her eyes. “Don't you two ever sleep?” she asked.“Sorry, Mom,” I replied. “I guess we got a little carried away.”“Oh, don't apologize, Jeremy. When your father heard you he got so hot he gave me the best fucking I've had in months.” MP and I laughed.“Mom, I asked MP to marry me. She said 'yes.' That's why we were celebrating.”“I assumed that was a fait accompli. But it nice to know it's official. What will your parents say, MP?”“My mom will be thrilled. I don't care what my dad thinks.” We ate breakfast as Mom and MP talked about their plans for the future. They got along much better than I could have dreamed. Mom taught MP some of the simpler spells, mostly things to do with housework, cooking, and the like. She also taught her some defense spells; just in case. They made great companions for each other, too.We were home about a week when MP told me there was something we had to do. I took her to a florist where she bought a dozen white roses and a heavy ceramic vase. Then we went to the one place I dreaded; the cemetery. MP placed the flowers on Mandy's grave. I couldn't help myself; I started crying again. When MP took my hand I noticed she was crying as hard as I was. We went to visit Mandy every week and we cried every time. When her headstone was laid we planted flowers and marveled at how they bloomed even in the cold of winter.We decided to marry as soon as we could for two reasons. The first was to allow MP to share in my magical powers. As my wife she could tap into my abilities to supplement hers. The second was because her father was acting like an ass. First, he tried to snatch MP as we were coming out of the supermarket. You already know how far that got. I was just about to freeze him when MP held her hand up telling me to stop. I could see her reciting a spell she got from Mom. She held her thumb and forefinger apart and slowly moved them together. “Don't let them touch, MP, unless you want to kill him.” This spell was squeezing his balls and it wasn't long before he was on the pavement rolling around in agony.“Daddy,” MP began, “I don't want anything to do with you anymore. You're the one who threw me out, remember? You're the one who threw away all my clothes. If you ever try anything like this again I'll really hurt you.” This was the only time I had ever seen MP angry; she was magnificent! She joined me in the car. When we drove away her father was still lying on the pavement.About a week later he called the police in the middle of the night accusing me of kidnapping MP. It took us an hour to explain to the cops, with MP telling them repeatedly that there was no way she was ever going home and that as an eighteen year-old, she could live wherever she chose. The next day my dad's attorney obtained a restraining order, keeping him at least 100 feet away from his daughter.In mid-August we visited my grandfather. Mom teleported us and Grandpa would send us back. I wouldn't be able to do this until I became a warlock at twenty-one. Grandpa greeted us warmly in his home just outside St. Augustine, Florida. After hugging me he turned to MP. “And you are obviously Mary Patricia. I'd recognize you anywhere.” Seeing our confusion he had us follow him into his study. He pulled a thick leather-bound volume from a shelf. It was old, the leather cracked in several places. He had a page bookmarked. When he opened it he showed us a photo. Other than the clothes I would have sworn it was MP's twin. It was her great, great, great grandmother; Mary Patricia O'Brien. He told us what he knew about her: “She lived in a poor village owned by an English lord near Galway. He was a hard man who loved the ladies, especially young pretty ones like Mary Patricia O'Brien; yes, the same name as you. He forced her to sleep with him when she was only fourteen by threatening her family, so her powers were doomed on her eighteenth birthday. Of course, she became pregnant and, unfortunately, died in childbirth. That's why none of her descendants knew she was a witch.Remember, too, that in those days witches were burned so she couldn't do much in her defense without exposing herself. It was a bad situation all around. Now, Mary Patricia, I know you made a promise to my grandson. Feel free to honor your promise while you are here; it's important that you do. And, you'll make me feel young again, too.”That night MP climbed into bed spooning behind me. “Jeremy,” she whispered alluringly as she rubbed her hard nipples up and down my back. “Jeremy,” she continued, “I don't want to disappoint Grandpa. I know he wants us to fuck and enjoy each other. Besides; I'm really horny tonight.”“MP,” I said as I rolled over, “you're horny every night.”“Yeah, and every morning and every afternoon, too; I can't help myself; I love you.” She leaned up and planted a big wet kiss on my lips. Her tongue teased my lips; her finger teased my nipple. “Damn, MP, you know all my buttons, don't you?”“Of course, Jeremy, that's my job. Now, are we going to talk all night or make love?”“Hmm,” I whispered back, “tough choice.” MP gave me a playful elbow to the ribs as I pulled her on top of me. She rubbed her hot slit up and down my sceptre, riding me to hardness. She rose up and, looking me in the eyes, pulled me into her. I slid into her heavenly cunt slowly, enjoying how her muscles were rippling up and down my cock. “Damn, MP, how do you come up with all these things to do to me?“Didn't I just tell you? It's my job to take care of you.” She began a slow rocking motion, bending me within her muscular canal; creating friction that would ultimately help us both. I reached up to massage her fantastic firm breasts and leaned forward for a long kiss. When we broke it MP was really hot, “GIVE It To Me Jeremy! You Know I Love It Rough. Ram It Into Me!” I responded by forcing my big cock deep into her, bottoming out on every thrust. I knew I was getting close so I found her clit, teasing it with the edge of my fingernail. MP gave a tremendous shudder, shouting at the top of her lungs, “Oh, Jeremy!” She collapsed onto my chest just as I shot river after river of hot cum into her womb. I kissed her gently, rubbed her back, and put my arms around her. “Good night, darling. You are the best thing that's ever happened to me.” One more kiss and we were ready for sleep.We had a great visit with Grandpa and just before we were to leave he asked MP to stand before him. He put his hand on her forehead. “Mary Patricia, I'm imbuing you with some of my powers. I have more than I can possibly use and I can see you'll use them wisely. My grandson has made an excellent choice.”Turning to me he continued, ”You forgot something, didn't you, Jeremy? Mary Patricia is four generations removed from her full-witch ancestor so she didn't have any powers other than being able to intercept partial telepathic messages. But you have been depositing your seed in her several times a day for some time and every time you do she is picking up a tiny amount of your power. However, that won't last and, if I hadn't given her some of mine, she would not be able to share yours when you marry. She would have nothing to build upon. Tsk, tsk, Jeremy, you should have known better.” I felt stupid, but Grandpa smiled, hugged us both and said “good-bye.” In a twinkling we were back home.Chapter 17.Life calmed down considerably and after all the tumultuous times we'd had the peace was welcome. We decided to take the fall semester off after everything that had occurred to us. Mom and Dad thought it a smart move, too. We wed the week following Christmas shortly after MP and I had turned twenty. MP was raised in an Irish Catholic family so a church wedding was important to her. It was a small ceremony; Ted and Josh were ushers; Dad walked MP down the aisle. Her mother was an honored guest as was Grandpa. Her father wasn't invited and we were relieved when he didn't show up. Had he come he was going to have to deal with my mother's wrath; not something I'd like to describe here. We lived near Greenwich, Connecticut so after the ceremony Mom and Dad treated all of us to dinner at Manero's, a fabulous and famous steak house originally owned by pro golfer Tony Manero who had won the 1936 US Open. In addition to wonderful steaks Manero's is reputed to have the best garlic bread ever. They claim that the best defense against their garlic bread is to have some yourself. Grandpa passed the basket to me. “Thanks, Grandpa, but I think I'll pass.”The entire group laughed wildly when MP said, “Um; me, too.” That was one of the few times I ever saw MP turn red with embarrassment. Everyone there knew we had been making love for years so I never did figure out what the big deal was. We flew to the Riviera Maya in Mexico for a honeymoon courtesy of Grandpa. A warlock buddy of his was the manager of a beautiful oceanfront hotel. He took great care of us. We swam and sunned, ate wonderful food, and made beautiful love over and over and over. Our wedding night MP came out of the bathroom wearing a sexy white teddy. She slinked rather than walked until she was halfway across the room. Then she dropped to the floor and slowly crawled. I

Maura Fernanda, una talentosa escritora y artista, encuentra en las palabras y los lienzos las formas más puras de expresar su sentir sobre la vida. Maura tiene el don de transformar las tragedias en arte, encontrando belleza y significado en el dolor. Ha publicado tres libros que han dejado una marca imborrable en sus lectores: - Una y Cien Vidas - Para las Ausencias - Habitación 9 Con muchos proyectos en camino, Maura sigue su travesía artística, tocando corazones y mentes con su creatividad y capacidad para inspirar. Su obra es un testimonio de su habilidad para conectar, emocionar e inspirar a través del arte. En este podcast platicamos sobre: *Cómo contar tu historia por medio de la escritura. *Los retos de ser escritor independiente. *Como Maura emprendió su sueño de ser artista multidisciplinaria. *Proceso para publicar una novela.

Hoy,  nos toca mirar a Cámara Zaragoza.  Y las del "Diario económico" nos hemos metido hasta la trastienda de los eventos, jornadas o simposios. Para que todo salga a la perfección, de manera impecable y, sobre todo, genere una buena experiencia en los asistentes hay detrás un enorme y concienzudo trabajo previo. Nos lo han contado Nathalia Antas, gerente de Zaragoza Servicios; Mónica Manero de Augusta Aragón; Marta Ribot, fundadora y gerente de Doña Col y Pilar Fernández, responsable de Club Cámara.

Go online to PeerView.com/BXU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Myelodysplastic syndromes (MDS) encompass a diverse group of myeloid malignancies, and new data are changing what can be considered “optimal” care. In this “Seminar and Workshop” activity, two hematology-oncology experts employ case-centric discussions to provide experienced instruction on the changing nature of individualized care for patients with MDS. This activity includes updated evidence supporting the use of innovative therapies for first-line management of MDS anemia, how to treat patients with ESA-refractory MDS, and treatment strategies for individuals presenting with high-risk mutations or cytogenetics. Watch now and take your treatment plans for patients with MDS to new heights! Upon completion of this activity, participants should be better able to: Cite clinical, cytogenetic, and molecular features that can inform timely, accurate diagnosis and prognosis in the MDS setting; Describe the evidence that supports the use of innovative therapeutics, including erythroid maturation agents, telomerase inhibitors, hypomethylating agent platforms, BCL2 inhibitors, and immunotherapy, in the management of patients with low-risk or high-risk MDS; Develop personalized MDS treatment protocols for the first-line management of anemia, in the ESA-refractory setting, and for patients presenting with high-risk MDS subtypes; and Address practical aspects of modern MDS therapy, including appropriate dose selection, response monitoring, and therapy-related adverse events management

Go online to PeerView.com/BXU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Myelodysplastic syndromes (MDS) encompass a diverse group of myeloid malignancies, and new data are changing what can be considered “optimal” care. In this “Seminar and Workshop” activity, two hematology-oncology experts employ case-centric discussions to provide experienced instruction on the changing nature of individualized care for patients with MDS. This activity includes updated evidence supporting the use of innovative therapies for first-line management of MDS anemia, how to treat patients with ESA-refractory MDS, and treatment strategies for individuals presenting with high-risk mutations or cytogenetics. Watch now and take your treatment plans for patients with MDS to new heights! Upon completion of this activity, participants should be better able to: Cite clinical, cytogenetic, and molecular features that can inform timely, accurate diagnosis and prognosis in the MDS setting; Describe the evidence that supports the use of innovative therapeutics, including erythroid maturation agents, telomerase inhibitors, hypomethylating agent platforms, BCL2 inhibitors, and immunotherapy, in the management of patients with low-risk or high-risk MDS; Develop personalized MDS treatment protocols for the first-line management of anemia, in the ESA-refractory setting, and for patients presenting with high-risk MDS subtypes; and Address practical aspects of modern MDS therapy, including appropriate dose selection, response monitoring, and therapy-related adverse events management

Go online to PeerView.com/BXU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Myelodysplastic syndromes (MDS) encompass a diverse group of myeloid malignancies, and new data are changing what can be considered “optimal” care. In this “Seminar and Workshop” activity, two hematology-oncology experts employ case-centric discussions to provide experienced instruction on the changing nature of individualized care for patients with MDS. This activity includes updated evidence supporting the use of innovative therapies for first-line management of MDS anemia, how to treat patients with ESA-refractory MDS, and treatment strategies for individuals presenting with high-risk mutations or cytogenetics. Watch now and take your treatment plans for patients with MDS to new heights! Upon completion of this activity, participants should be better able to: Cite clinical, cytogenetic, and molecular features that can inform timely, accurate diagnosis and prognosis in the MDS setting; Describe the evidence that supports the use of innovative therapeutics, including erythroid maturation agents, telomerase inhibitors, hypomethylating agent platforms, BCL2 inhibitors, and immunotherapy, in the management of patients with low-risk or high-risk MDS; Develop personalized MDS treatment protocols for the first-line management of anemia, in the ESA-refractory setting, and for patients presenting with high-risk MDS subtypes; and Address practical aspects of modern MDS therapy, including appropriate dose selection, response monitoring, and therapy-related adverse events management

Go online to PeerView.com/BXU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Myelodysplastic syndromes (MDS) encompass a diverse group of myeloid malignancies, and new data are changing what can be considered “optimal” care. In this “Seminar and Workshop” activity, two hematology-oncology experts employ case-centric discussions to provide experienced instruction on the changing nature of individualized care for patients with MDS. This activity includes updated evidence supporting the use of innovative therapies for first-line management of MDS anemia, how to treat patients with ESA-refractory MDS, and treatment strategies for individuals presenting with high-risk mutations or cytogenetics. Watch now and take your treatment plans for patients with MDS to new heights! Upon completion of this activity, participants should be better able to: Cite clinical, cytogenetic, and molecular features that can inform timely, accurate diagnosis and prognosis in the MDS setting; Describe the evidence that supports the use of innovative therapeutics, including erythroid maturation agents, telomerase inhibitors, hypomethylating agent platforms, BCL2 inhibitors, and immunotherapy, in the management of patients with low-risk or high-risk MDS; Develop personalized MDS treatment protocols for the first-line management of anemia, in the ESA-refractory setting, and for patients presenting with high-risk MDS subtypes; and Address practical aspects of modern MDS therapy, including appropriate dose selection, response monitoring, and therapy-related adverse events management

Go online to PeerView.com/BXU860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Myelodysplastic syndromes (MDS) encompass a diverse group of myeloid malignancies, and new data are changing what can be considered “optimal” care. In this “Seminar and Workshop” activity, two hematology-oncology experts employ case-centric discussions to provide experienced instruction on the changing nature of individualized care for patients with MDS. This activity includes updated evidence supporting the use of innovative therapies for first-line management of MDS anemia, how to treat patients with ESA-refractory MDS, and treatment strategies for individuals presenting with high-risk mutations or cytogenetics. Watch now and take your treatment plans for patients with MDS to new heights! Upon completion of this activity, participants should be better able to: Cite clinical, cytogenetic, and molecular features that can inform timely, accurate diagnosis and prognosis in the MDS setting; Describe the evidence that supports the use of innovative therapeutics, including erythroid maturation agents, telomerase inhibitors, hypomethylating agent platforms, BCL2 inhibitors, and immunotherapy, in the management of patients with low-risk or high-risk MDS; Develop personalized MDS treatment protocols for the first-line management of anemia, in the ESA-refractory setting, and for patients presenting with high-risk MDS subtypes; and Address practical aspects of modern MDS therapy, including appropriate dose selection, response monitoring, and therapy-related adverse events management

Drs Garcia-Manero and Zeidan discuss the significance of efficacy and safety data from the COMMANDS trial in MDS, takeaways from the subgroup analyses, and expectations around treatment sequencing in the lower-risk MDS population.

Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, live at the Eleventh Annual Meeting of the Society of Hematologic Oncology to discuss the phase III COMMANDS trial, the recent approval of luspatercept, and other developments in myelodysplastic syndromes (MDS) treatment and research. Dr. Garcia-Manero spoke about the design of the phase III COMMANDS trial, which evaluated luspatercept versus epoetin alfa for the treatment of anemia in patients with lower-risk MDS who required red blood cell (RBC) transfusions but had not previously received an erythropoiesis-stimulating agent. “The study is very interesting in that it's very well controlled … and the data [are] very clear,” he said. The phase III trial showed 58.5% of patients receiving luspatercept achieved the primary endpoint of RBC transfusion independence for at least 12 weeks with a mean hemoglobin increase of at least 1.5 g/dL within the first 24 weeks, while this was only reported in 31.2% of patients receiving epoetin alfa.

Alex Pring was born with one arm. His other extends to his forearm and stops. As he started growing up and going to school, he had some questions about his limb difference. “I kinda asked the question, ‘Why can't I have an arm? Everyone else has an arm, why don't I,'” Pring said. He said his mom loves solving problems, so she reached out to the University of Central Florida and a student helped to create his very first arm. Then, that student, Albert Manero, went on to launch Limbitless Solutions, a company that makes prosthetics for children. Manero then upgraded Pring's arm, giving it an “Iron Man” design, and invited Robert Downey Jr. to present it to him in 2015. The moment went viral. Pring said the experience, “was probably the biggest time for any 7-year-old possible.” The first version of the arm helped him to hold a pencil, and the “Iron Man” arm helped him to build confidence, but because he is growing so fast, he said he needs to be resized regularly and sometimes he goes without his prosthetic. That includes when he is doing football conditioning. Pring said he power cleans 135 pounds with one arm. He said his teammates at South Lake High School are often surprised at what he can pull off. And, his opponents often underestimate him. “In one of our games, the seniors told me all the players were trash-talking me saying, ‘There is no way this one-armed kid can do it.' Next play, I destroyed the running back,” Pring said. It's not always easy, but he said he gets his confidence from his parents. “They have taught me every single day of my life, work hard and you will be rewarded at the end of the day,” he said. Pring said he would love to eventually play football professionally and that he looks up to Shaquem Griffin, the former University of Central Florida, football player who also has a limb difference and went on to play for the NFL. But, if football doesn't pan out, Pring said he would like to go UCF to pursue aerospace engineering, the same degree Manero pursued. To learn more about Pring and how he is making an impact on and off the field check out Florida's Fourth Estate. Learn more about your ad choices. Visit megaphone.fm/adchoices

Itziar Manero da el salto al largometraje como una de las protagonistas de la primera película de Itsaso Arana 'Las chicas están bien'. Hoy charlamos con las dos sobre este cuento de verano.   Escuchar audio

Inside the Issue: Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes — Faculty Presentation 1: Current management of higher-risk myelodysplastic syndromes (MDS) — Guillermo Garcia-Manero, MD CME information and select publications  

Go online to PeerView.com/TVR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Rapid change is coming to the management of myelodysplastic syndromes (MDS), fueled by new science that will expand the therapeutic possibilities for managing different patient populations and impact the management team. But are you ready to be a team player and help revolutionize MDS care? Find out by viewing this PeerView “Clinical Consults” activity based on a symposium held during the 2023 ASCO Annual Meeting. Watch as an expert panel provides insights on the use of innovative therapies for the first-line management of MDS anemia, the treatment of ESA-refractory patients, and management of patients presenting with high-risk disease. Throughout, they will also provide practical insights for effective delivery of care, including patient education, appropriate dosing, and adverse event management. Don't miss this opportunity to see how your team can take command of care when managing your patients with MDS! Upon completion of this activity, participants should be better able to: Discuss molecular and pathologic features, risk factors, and clinical signs that can inform a timely team-based diagnostic and prognostic assessment of MDS; Cite clinical evidence supporting the use of innovative therapeutics with unique mechanisms of action for the management of patients with low-risk or high-risk MDS; Develop risk-adapted team management of protocols for patients with MDS, including for the first-line management of anemia, in the ESA-failing setting, or for patients presenting with higher-risk genomic subtypes; and Recommend team-based strategies to manage therapy delivery considerations in the MDS setting, including selection of appropriate dosing, response monitoring, and management of therapy-related adverse events

Go online to PeerView.com/TVR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Rapid change is coming to the management of myelodysplastic syndromes (MDS), fueled by new science that will expand the therapeutic possibilities for managing different patient populations and impact the management team. But are you ready to be a team player and help revolutionize MDS care? Find out by viewing this PeerView “Clinical Consults” activity based on a symposium held during the 2023 ASCO Annual Meeting. Watch as an expert panel provides insights on the use of innovative therapies for the first-line management of MDS anemia, the treatment of ESA-refractory patients, and management of patients presenting with high-risk disease. Throughout, they will also provide practical insights for effective delivery of care, including patient education, appropriate dosing, and adverse event management. Don't miss this opportunity to see how your team can take command of care when managing your patients with MDS! Upon completion of this activity, participants should be better able to: Discuss molecular and pathologic features, risk factors, and clinical signs that can inform a timely team-based diagnostic and prognostic assessment of MDS; Cite clinical evidence supporting the use of innovative therapeutics with unique mechanisms of action for the management of patients with low-risk or high-risk MDS; Develop risk-adapted team management of protocols for patients with MDS, including for the first-line management of anemia, in the ESA-failing setting, or for patients presenting with higher-risk genomic subtypes; and Recommend team-based strategies to manage therapy delivery considerations in the MDS setting, including selection of appropriate dosing, response monitoring, and management of therapy-related adverse events

Go online to PeerView.com/TVR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Rapid change is coming to the management of myelodysplastic syndromes (MDS), fueled by new science that will expand the therapeutic possibilities for managing different patient populations and impact the management team. But are you ready to be a team player and help revolutionize MDS care? Find out by viewing this PeerView “Clinical Consults” activity based on a symposium held during the 2023 ASCO Annual Meeting. Watch as an expert panel provides insights on the use of innovative therapies for the first-line management of MDS anemia, the treatment of ESA-refractory patients, and management of patients presenting with high-risk disease. Throughout, they will also provide practical insights for effective delivery of care, including patient education, appropriate dosing, and adverse event management. Don't miss this opportunity to see how your team can take command of care when managing your patients with MDS! Upon completion of this activity, participants should be better able to: Discuss molecular and pathologic features, risk factors, and clinical signs that can inform a timely team-based diagnostic and prognostic assessment of MDS; Cite clinical evidence supporting the use of innovative therapeutics with unique mechanisms of action for the management of patients with low-risk or high-risk MDS; Develop risk-adapted team management of protocols for patients with MDS, including for the first-line management of anemia, in the ESA-failing setting, or for patients presenting with higher-risk genomic subtypes; and Recommend team-based strategies to manage therapy delivery considerations in the MDS setting, including selection of appropriate dosing, response monitoring, and management of therapy-related adverse events

Go online to PeerView.com/TVR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Rapid change is coming to the management of myelodysplastic syndromes (MDS), fueled by new science that will expand the therapeutic possibilities for managing different patient populations and impact the management team. But are you ready to be a team player and help revolutionize MDS care? Find out by viewing this PeerView “Clinical Consults” activity based on a symposium held during the 2023 ASCO Annual Meeting. Watch as an expert panel provides insights on the use of innovative therapies for the first-line management of MDS anemia, the treatment of ESA-refractory patients, and management of patients presenting with high-risk disease. Throughout, they will also provide practical insights for effective delivery of care, including patient education, appropriate dosing, and adverse event management. Don't miss this opportunity to see how your team can take command of care when managing your patients with MDS! Upon completion of this activity, participants should be better able to: Discuss molecular and pathologic features, risk factors, and clinical signs that can inform a timely team-based diagnostic and prognostic assessment of MDS; Cite clinical evidence supporting the use of innovative therapeutics with unique mechanisms of action for the management of patients with low-risk or high-risk MDS; Develop risk-adapted team management of protocols for patients with MDS, including for the first-line management of anemia, in the ESA-failing setting, or for patients presenting with higher-risk genomic subtypes; and Recommend team-based strategies to manage therapy delivery considerations in the MDS setting, including selection of appropriate dosing, response monitoring, and management of therapy-related adverse events

Go online to PeerView.com/TVR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Rapid change is coming to the management of myelodysplastic syndromes (MDS), fueled by new science that will expand the therapeutic possibilities for managing different patient populations and impact the management team. But are you ready to be a team player and help revolutionize MDS care? Find out by viewing this PeerView “Clinical Consults” activity based on a symposium held during the 2023 ASCO Annual Meeting. Watch as an expert panel provides insights on the use of innovative therapies for the first-line management of MDS anemia, the treatment of ESA-refractory patients, and management of patients presenting with high-risk disease. Throughout, they will also provide practical insights for effective delivery of care, including patient education, appropriate dosing, and adverse event management. Don't miss this opportunity to see how your team can take command of care when managing your patients with MDS! Upon completion of this activity, participants should be better able to: Discuss molecular and pathologic features, risk factors, and clinical signs that can inform a timely team-based diagnostic and prognostic assessment of MDS; Cite clinical evidence supporting the use of innovative therapeutics with unique mechanisms of action for the management of patients with low-risk or high-risk MDS; Develop risk-adapted team management of protocols for patients with MDS, including for the first-line management of anemia, in the ESA-failing setting, or for patients presenting with higher-risk genomic subtypes; and Recommend team-based strategies to manage therapy delivery considerations in the MDS setting, including selection of appropriate dosing, response monitoring, and management of therapy-related adverse events

The Brooklyn Cafe Show today's guests Carolina Ayala Todo Bello Ballons , Alan Espinar &Carolina Manero Financal experts 786-830 1957-4075342601 Thrisna Brooklyn Cafe show crew --- Support this podcast: https://podcasters.spotify.com/pod/show/thebrooklyncafe/support

204 aspirantes a consejeros del INE aprueban examenGobierno presenta al Congreso una reforma al artículo 33Afganistán es el país más represivo contra la mujeres: ONUMás información en nuestro podcast

Episode 142 we are honored to welcome in three time Pennsylvania High School 6A champion coaches from North Penn, Head Coach Kevin Manero, and Assistant Coach Frank Yanni. We discuss Kevin's journey to becoming the head coach, building and sustaining a program in the most competitive league in the state, recognizing talent, the greats who have played in the program, facing future D1 and Pro talent, MLB changes for 2023, and we finish up with a quick outlook for the 2023 season. Great insight to and unbelievable High School baseball program. Hosted by our great friend of the show Jack Horan.

En el podcast de con #ChayoContigo, nuestra invitada especial, la Dra. Consuelo Manero Soto, habló sobre la menopausia y también hablamos de las llamadas de atención y la comunicación con los hijos. No te pierdas este podcast de Chayo con temas familiares, adolescencia, educación, consejos de vida y más.

John's websiteshttps://livefree.academy/https://odysee.com/@johnbushlivefreenow:cMake a Donation to Forbidden Knowledge News http://supportfkn.comhttps://www.paypal.me/forbiddenknowledgeneThe Forbidden Knowledge Network https://forbiddenknowledge.news/Sign up for remote viewing classes!https://www.irva.org/events/registrationCentropix Frequency Healing Devices https://linktr.ee/CentropixC60 PurplePower https://go.c60purplepower.com/knowledge10/Become Self-Sufficient With A Food Forest!!https://foodforestabundance.com/get-started/?ref=CHRISTOPHERMATHUse coupon code: FORBIDDENJustin Pedini's Facebook and YouTube https://www.facebook.com/profile.php?id=100078444041811https://youtube.com/user/SOLIDPEDINIhttps://www.tiktok.com/t/ZTRPXe3xS/One Great Work Network https://onegreatworknetwork.com/Karen Holton https://karenholtonhealthcoach.comSustainable Communities Telegram Grouphttps://t.me/+kNxt1F0w-_cwYmExThe FKN Store!https://www.fknstore.net/